MedPath

In-vivo Bioequivalence Test of Metformin ER tablets1000 mg Kooshan Pharmed with brand drug (Glucophage® 1000 mg ER Tablet ,Merck Sharp & Dohme, German)

Not Applicable
Recruiting
Conditions
Bio equivalence test.
Registration Number
IRCT20200105046010N70
Lead Sponsor
Koushan Pharmed Pharmaceutical Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria

General health
Body mass index between18-28
Informed consent
Being at the age of 18-55 years old

Exclusion Criteria

Smoking
A history of cardiovascular disease
A history of liver & kidney disease
Pregnancy
Alcohol & Drug addiction
Hypersensitivity to the dru

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Plasma drug concentration. Timepoint: Sampling times in this study will be 0? 0.5? 1? 1.5? 2? 2.5? 3? 3.5? 4? 4.5? 5? 6? 10 .8? 12 , 24 hours after prescribing the tablet. Method of measurement: High Performance Liquid Chromatography with tandem mass spectroscopy detector.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath